Table 1.
Characteristics of gynecologic cancer patients after initial diagnosis in a radiation oncology.
| Endometrial carcinoma (n = 554) |
Uterine sarcoma (n = 21) |
Cervical cancer (n = 269) |
Ovarian cancer (n = 27) |
Vulvar cancer (n = 26) |
Vaginal cancer (n = 14) |
|
|---|---|---|---|---|---|---|
| % (n) | ||||||
| Age group | ||||||
| < 30 | 0.2 (1) | – | 2 (6) | 4 (1) | – | – |
| 30-39 | 2.9 (16) | 5 (1) | 10 (26) | – | – | – |
| 40-49 | 10.1 (56) | 33 (7) | 25 (68) | 19 (5) | 4 (1) | 7 (1) |
| 50-59 | 35.6 (197) | 43 (9) | 32 (87) | 44 (12) | 19 (5) | 22 (3) |
| 60-69 | 36.8 (204) | 9.5 (2) | 20 (54) | 22 (6) | 23 (6) | 57 (8) |
| ≥ 70 | 14.4 (80) | 9.5 (2) | 11 (28) | 11 (3) | 54 (14) | 14 (2) |
| FIGO stage | ||||||
| I | 69.3 (384) | 57 (12) | 24 (64) | – | 46 (12) | 21 (3) |
| II | 14.8 (82) | 19 (4) | 40 (109) | – | 23 (6) | 29 (4) |
| III | 15.5 (86) | 19 (4) | 31 (83) | 7 (2) | 19 (5) | 36 (5) |
| IV | 0.4 (2) | 5 (1) | 5 (13) | 93 (25) | 12 (3) | 14 (2) |
| SEER stage | ||||||
| Localized | 69 (384) | 57 (12) | 24 (64) | – | 46 (12) | 22 (3) |
| Regional | 30(168) | 38 (8) | 71 (192) | 7 (2) | 42 (11) | 64 (9) |
| Distant | 1 (2) | 5 (1) | 5 (13) | 93 (25) | 12 (3) | 14 (2) |
| Treatment | ||||||
| Curative | 99.6 (552) | 95 (20) | 99 (267) | 15 (4) | 100 (26) | 93 (13) |
| - No RT | 17 (96) | 40 (8) | 2 (5) | – | 8 (2) | – |
| -Definitive RT | – | – | 62 (167) | 100 (4) | 46 (12) | 62 (8) |
| -Adjuvant RT | 83 (456) | 60 (12) | 36 (95) | – | 46 (12) | 38 (5) |
| Palliative RT | 0.4 (2) | 5 (1) | 1 (2) | 85 (23) | – | 7 (1) |
| RT technique | ||||||
| No | 17 (96) | 38 (8) | 2 (5) | – | 8 (2) | – |
| Yes | 83 (458) | 62 (13) | 98 (264) | 100 (27) | 92 (24) | 100 (14) |
| -BRA alone | 51 (235) | – | – | – | – | – |
| -EBRT alone | 13 (58) | 69 (9) | 9 (24) | 100 (27) | 100 (24) | 29 (4) |
| -EBRT + BRA | 36 (165) | 31 (4) | 91 (240) | – | – | 71 (10) |
| Relapse* | ||||||
| No | 85 (468) | 50 (10) | 72 (192) | 25 (1) | 35 (9) | 69 (9) |
| Yes | 15 (84) | 50 (10) | 28 (75) | 75 (3) | 65 (17) | 31 (4) |
| -Locoregional | 26 (22) | 30 (3) | 36 (27) | 67 (2) | 65 (11) | 75 (3) |
| -Distant | 74 (62) | 70 (7) | 64 (48) | 33 (1) | 35 (6) | 25 (1) |
FIGO, International Federation of Gynecology and Obstetrics; SEER, Surveillance, Epidemiology, and End Results (National Cancer Institute, United States of America); RT, radiotherapy; BRA, brachytherapy; EBRT, external beam radiotherapy; *, only for patients treated curatively.